Cytokines: value-added products in hematopoietic stem cell gene therapy (Q35856135)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published in August 2004

Language	Label	Description	Also known as
English	Cytokines: value-added products in hematopoietic stem cell gene therapy	scientific article published in August 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

1 reference

Europe PubMed Central

Cytokines: value-added products in hematopoietic stem cell gene therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

0 references

author name string

Steven P Zielske

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Stephen E Braun

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

publication date

1 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Molecular Therapy

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

211-219

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

The capacity of peripheral blood stem cells mobilised with chemotherapy plus G-CSF to repopulate irradiated marrow stroma in vitro is similar to that of bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Comparison of rhG--CSF primed bone marrow and blood stem cell autografts: an analysis of engraftment in malignant lymphomas and solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Granulocyte colony-stimulating factor mobilized peripheral blood stem cells enter into G1 of the cell cycle and express higher levels of amphotropic retrovirus receptor mRNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Retroviral transduction efficiency of G-CSF+SCF-mobilized peripheral blood CD34+ cells is superior to G-CSF or G-CSF+Flt3-L-mobilized cells in nonhuman primates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Direct comparison of steady-state marrow, primed marrow, and mobilized peripheral blood for transduction of hematopoietic stem cells in dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Integration of murine leukemia virus DNA depends on mitosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Engraftment of gene-marked hematopoietic progenitors in myeloma patients after transplant of autologous long-term marrow cultures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

The relative quiescence of hematopoietic stem cells in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Cytokines, including stem cell factor alone, enhance lentiviral transduction in nondividing human LTCIC and NOD/SCID repopulating cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Fibronectin fragment CH-296 inhibits apoptosis and enhances ex vivo gene transfer by murine retrovirus and human lentivirus vectors independent of viral tropism in nonhuman primate CD34+ cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Highly efficient lentiviral gene transfer in CD34+ and CD34+/38-/lin- cells from mobilized peripheral blood after cytokine prestimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Transduction of Human CD34+CD38- Bone Marrow and Cord Blood-Derived SCID-Repopulating Cells with Third-Generation Lentiviral Vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Distinct hematopoietic stem/progenitor cell populations are responsible for repopulating NOD/SCID mice compared with nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Stable transduction with lentiviral vectors and amplification of immature hematopoietic progenitors from cord blood of preterm human fetuses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Impaired bone marrow homing of cytokine-activated CD34+ cells in the NOD/SCID model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

The human immunodeficiency virus (HIV)-type 1 coreceptor CXCR-4 (fusin) is preferentially expressed on the more immature CD34+ hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Ex vivo treatment of proliferating human cord blood stem cells with stroma-derived factor-1 enhances their ability to engraft NOD/SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

SDF-1alpha/CXCL12 enhances retroviral-mediated gene transfer into immature subsets of human and murine hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Primary structure and functional expression of rat and human stem cell factor DNAs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Cloning, sequence, and expression of a human granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Efficient transduction of human lymphocytes and CD34+ cells via human immunodeficiency virus-based gene transfer vectors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G0 lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YMTHE.2004.05.025

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35856135&oldid=1710435765"